Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Queensland Health
Daiichi Sankyo
Colorcon
Johnson and Johnson
Fuji
Teva
Cantor Fitzgerald
Deloitte

Generated: June 19, 2018

DrugPatentWatch Database Preview

DESOXYN Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Desoxyn patents expire, and when can generic versions of Desoxyn launch?

Desoxyn is a drug marketed by Recordati Rare and is included in one NDA.

The generic ingredient in DESOXYN is methamphetamine hydrochloride. There are six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the methamphetamine hydrochloride profile page.
Drug patent expirations by year for DESOXYN
Synonyms for DESOXYN
(.+-.)-Deoxyephedrine
(+-)-Desoxyephedrine
(+-)-Methamphetamine
(+-)-N-Methylamphetamine
(+-)-N,alpha-Dimethylbenzeneethanamine
(+-)-N,alpha-Dimethylphenethylamine
(+/-)-Deoxyephedrine
(+/-)-Methamphetamine
(+/-)-N-Methylamphetamine
(+/-)-N,alpha-Dimethylbenzeneethanamine
(+/-)-N,alpha-Dimethylphenethylamine
(2-Methylaminopropyl)benzene
(R)Methyl-(1-methyl-2-phenyl-ethyl)-amine
1-Phenyl-2-methylaminopropan
2-(Methylamino)-1-phenylpropane
30639-16-8
4-12-00-02589 (Beilstein Handbook Reference)
4846-07-5
7632-10-2
AC1L1AYH
AC1Q40T5
AK398932
AKOS008901219
alpha-phenyl-beta-methlaminopropane
alpha-Phenyl-beta-methylaminopropane
Anadrex
BDBM50009057
Benzeneethan-a,b-d2-amine, a-methyl-N-(methyl-d3)-
Benzeneethanamine, N,.alpha.-dimethyl-
Benzeneethanamine, N,.alpha.-dimethyl-, (R)-
Benzeneethanamine, N,.alpha.-dimethyl-, (S)-
Benzeneethanamine, N,alpha-dimethyl-
Benzeneethanamine, N,beta-dimethyl-
Benzeneethanamine,.alpha.-dimethyl-, (.+-.)-
Benzeneethanamine,dimethyl- (9CI)
BRN 1072499
C10H15N
CTK4G2699
d-Deoxyephedrine solution
d,l-Methamphetamine
Deoxyephedrine
Desoxyephedrine
Desoxyephedrine
Methamfetamine
Pervitin
Anadrex
Methedrine
Methylamphetamine
Syndrox
Desoxyn
DivK1c_000988
DL-1-Phenyl-2(methylamino)propane solution
dl-Desoxyephedrine
dl-Methamphetamin
DL-Methamphetamine
DL-Methamphetamine solution
DTXSID3043861
EINECS 231-559-0
Ephedrine, deoxy-
FT-0693480
GTPL4803
IDI1_000988
J-523644
KBio1_000988
LS-103329
LS-103332
LS-103333
MAMP
METHAMPHETAMINE (-)
METHAMPHETAMINE (+)
Methyl-(1-methyl-2-phenyl-ethyl)-amine
Methyl-(1-methyl-2-phenyl-ethyl)-amine(methamphetamine)
MYWUZJCMWCOHBA-UHFFFAOYSA-N
N-Methyl-1-phenyl-2-propylamine
N-Methyl-1-phenyl-isopropylamine
N-methyl-1-phenylpropan-2-amine
N,alpha-Dimethylbenzeneethanamine
N,alpha-Dimethylphenethylamine
NCGC00247330-01
NCGC00247330-02
NINDS_000988
NSC-403767
NSC403767
OR014460
Pervertin
Phenethylamine, N,.alpha.-dimethyl-
Phenethylamine, N,.alpha.-dimethyl-, (S)-(+)-
Phenethylamine, N,.alpha.-dimethyl-, D-
PHENETHYLAMINE, N,alpha-DIMETHYL-
Phenethylamine, N,alpha-dimethyl- (8CI)
Phenethylamine,.alpha.-dimethyl-, (.+-.)-
rac-Methamphetamine
rac-Methamphetamine 0.1 mg/ml in Methanol
rac-Methamphetamine 1.0 mg/ml in Methanol
Racemic methyl amphetamine
SCHEMBL42178

US Patents and Regulatory Information for DESOXYN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Recordati Rare DESOXYN methamphetamine hydrochloride TABLET, EXTENDED RELEASE;ORAL 005378-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Recordati Rare DESOXYN methamphetamine hydrochloride TABLET;ORAL 005378-002 Approved Prior to Jan 1, 1982 AA RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Recordati Rare DESOXYN methamphetamine hydrochloride TABLET, EXTENDED RELEASE;ORAL 005378-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Recordati Rare DESOXYN methamphetamine hydrochloride TABLET, EXTENDED RELEASE;ORAL 005378-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Julphar
McKinsey
Baxter
US Department of Justice
Colorcon
Chubb
Harvard Business School
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.